Percentage of Participants Who Develop Skin Rash 30 Days [clinicaltrials_resource:6337307b35146a8e1ccfd75bdac31b87]
Skin rash was assessed by the investigator and dermatologists (the latter ones only through pictures) and scored according to (National cancer Institute -Common Terminology Criteria for Adverse Events ) NCI-CTCAE ( version 3 (line "Rash/desquamation" - short name "rash").
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Percentage of Participants Who Develop Skin Rash 30 Days [clinicaltrials_resource:6337307b35146a8e1ccfd75bdac31b87]
Skin rash was assessed by the investigator and dermatologists (the latter ones only through pictures) and scored according to (National cancer Institute -Common Terminology Criteria for Adverse Events ) NCI-CTCAE ( version 3 (line "Rash/desquamation" - short name "rash").
Bio2RDF identifier
6337307b35146a8e1ccfd75bdac31b87
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6337307b35146a8e1ccfd75bdac31b87
measure [clinicaltrials_vocabulary:measure]
Percentage of Participants Who Develop Skin Rash
time frame [clinicaltrials_vocabulary:time-frame]
description
Skin rash was assessed by the ...... amation" - short name "rash").
identifier
clinicaltrials_resource:6337307b35146a8e1ccfd75bdac31b87
title
Percentage of Participants Who Develop Skin Rash 30 Days
@en
type
label
Percentage of Participants Who ...... 7307b35146a8e1ccfd75bdac31b87]
@en